awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33414307-3462C3ED-EEAC-4E92-B06E-DEA0F3925F06
Q33414307-3462C3ED-EEAC-4E92-B06E-DEA0F3925F06
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414307-3462C3ED-EEAC-4E92-B06E-DEA0F3925F06
A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma.
P2860
Q33414307-3462C3ED-EEAC-4E92-B06E-DEA0F3925F06
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414307-3462C3ED-EEAC-4E92-B06E-DEA0F3925F06
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fcfc5d854116dc67e338ba12a3dfd2968f958be8
P2860
The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies.